A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles